Market Cap ₹175 Cr.
Stock P/E 0.0
P/B 2.3
Current Price ₹70
Book Value ₹ 30.2
Face Value 10
52W High ₹106
Dividend Yield 0%
52W Low ₹ 51.5
Shri Techtex Ltd is a dynamic and innovative company specializing in advanced technical textiles. With a commitment to excellence, the company designs, manufactures, and distributes a diverse range of high-performance textile solutions for various industries. Leveraging cutting-edge technology and a skilled workforce, Shri Techtex Ltd delivers products tailored to meet specific client needs, including industrial fabrics, protective textiles, medical textiles, and more. Their products are known for their durability, functionality, and adherence to international quality standards. Through a customer-centric approach, Shri Techtex Ltd has established itself as a reliable partner for businesses seeking top-tier textile solutions, contributing to advancements in sectors ranging from manufacturing to healthcare.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|
| Net Sales | 16 | 39 | 51 | 57 | |
| Other Income | 0 | 1 | 1 | 1 | |
| Total Income | 16 | 40 | 52 | 58 | |
| Total Expenditure | 8 | 21 | 39 | 44 | |
| Operating Profit | 8 | 19 | 13 | 14 | |
| Interest | 1 | 1 | 1 | 1 | |
| Depreciation | 1 | 1 | 1 | 1 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 6 | 17 | 11 | 12 | |
| Provision for Tax | 2 | 4 | 2 | 3 | |
| Profit After Tax | 4 | 13 | 8 | 9 | |
| Adjustments | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 4 | 13 | 8 | 9 | |
| Adjusted Earnings Per Share | 2.5 | 7.2 | 4.7 | 5.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 12% | 53% | 0% | 0% |
| Operating Profit CAGR | 8% | 21% | 0% | 0% |
| PAT CAGR | 13% | 31% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 36% | 54% | 55% | 55% |
| ROCE Average | 23% | 42% | 44% | 44% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Shareholder's Funds | 8 | 21 | 21 | 30 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 5 | 14 | 19 | 25 |
| Other Non-Current Liabilities | 3 | 5 | 0 | 7 |
| Total Current Liabilities | 2 | 7 | 12 | 12 |
| Total Liabilities | 18 | 47 | 53 | 74 |
| Fixed Assets | 10 | 12 | 37 | 38 |
| Other Non-Current Assets | 2 | 13 | 1 | 1 |
| Total Current Assets | 6 | 22 | 15 | 34 |
| Total Assets | 18 | 47 | 53 | 74 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 1 | 0 |
| Cash Flow from Operating Activities | 1 | 4 | 22 | -8 |
| Cash Flow from Investing Activities | -0 | -14 | -13 | -3 |
| Cash Flow from Financing Activities | 0 | 11 | -9 | 11 |
| Net Cash Inflow / Outflow | 0 | 0 | -0 | 1 |
| Closing Cash & Cash Equivalent | 0 | 1 | 0 | 1 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 2.55 | 7.21 | 4.71 | 5.19 |
| CEPS(Rs) | 3.16 | 7.86 | 5.34 | 5.9 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 4.61 | 11.83 | 11.97 | 17.16 |
| Core EBITDA Margin(%) | 47.92 | 45.79 | 23.96 | 21.97 |
| EBIT Margin(%) | 42.41 | 44.79 | 23.06 | 21.82 |
| Pre Tax Margin(%) | 37.9 | 42.54 | 20.78 | 20.4 |
| PAT Margin (%) | 27.82 | 32.07 | 16.15 | 16 |
| Cash Profit Margin (%) | 34.46 | 34.97 | 18.31 | 18.18 |
| ROA(%) | 25.32 | 39.44 | 16.64 | 14.38 |
| ROE(%) | 55.32 | 87.77 | 39.58 | 35.62 |
| ROCE(%) | 52.58 | 72.58 | 29.04 | 23.1 |
| Receivable days | 45.77 | 61.06 | 75.6 | 69.62 |
| Inventory Days | 45.91 | 16.96 | 21.37 | 51.3 |
| Payable days | 0 | 118.78 | 61.77 | 51.66 |
| PER(x) | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.42 | 0.42 | 0.52 | 0.85 |
| EV/Core EBITDA(x) | 0.85 | 0.88 | 2.04 | 3.55 |
| Net Sales Growth(%) | 0 | 145.52 | 29.67 | 11.23 |
| EBIT Growth(%) | 0 | 159.26 | -33.23 | 5.23 |
| PAT Growth(%) | 0 | 183 | -34.69 | 10.17 |
| EPS Growth(%) | 0 | 183 | -34.69 | 10.17 |
| Debt/Equity(x) | 0.6 | 0.72 | 1.17 | 1.06 |
| Current Ratio(x) | 2.73 | 3.15 | 1.24 | 2.84 |
| Quick Ratio(x) | 1.76 | 2.91 | 0.89 | 1.87 |
| Interest Cover(x) | 9.41 | 19.98 | 10.11 | 15.38 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
| # | Sep 2023 | Mar 2024 |
|---|---|---|
| Promoter | 70.34 | 70.34 |
| FII | 3.31 | 3.36 |
| DII | 1 | 0.39 |
| Public | 25.35 | 25.91 |
| Others | 0 | 0 |
| Total | 100 | 100 |
| # | Sep 2023 | Mar 2024 |
|---|---|---|
| Promoter | 1.76 | 1.76 |
| FII | 0.08 | 0.08 |
| DII | 0.03 | 0.01 |
| Public | 0.63 | 0.65 |
| Others | 0 | 0 |
| Total | 2.5 | 2.5 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
